It is a test that detects antibodies against the Hepatitis B surface antigen (HBsAg) to assess immunity to Hepatitis B.

It is recommended after Hepatitis B vaccination, recovery from Hepatitis B, or as part of routine screening.

No special preparation is required. Inform your healthcare provider of any recent vaccinations or Hepatitis B history.

Results are usually available within 24 to 48 hours after the blood sample is collected.

Positive results indicate immunity to Hepatitis B, while negative results may suggest the need for further evaluation or vaccination.

ICU Bedside Dialysis is a service provided in the Intensive Care Unit (ICU) for patients with kidney failure who require dialysis while remaining in the ICU for critical care.

Patients may need bedside dialysis if they have acute kidney injury or chronic kidney disease that requires dialysis while they are critically ill or unstable.

Bedside dialysis is performed using specialized equipment and techniques to remove waste products and excess fluids from the blood while the patient remains in the ICU.

Bedside dialysis allows for continuous monitoring and treatment of critically ill patients without needing to transport them to a separate dialysis unit, which can be safer and more convenient.

Risks include infection, bleeding, and complications related to the dialysis procedure. The ICU team closely monitors patients to manage and minimize these risks.

The Sputum AFB Test detects acid-fast bacilli in sputum, indicating a tuberculosis infection.

Provide sputum samples early in the morning in a sterile container. Avoid substances that might alter sputum consistency.

Results are typically available within 7 to 10 days due to the time needed for culturing and analysis.

It is essential for diagnosing tuberculosis, monitoring treatment progress, and preventing the spread of TB.

Book online through our website or contact our customer service team at Chirayu SuperSpeciality Hospital.